Secondary psychoses: An update

World Psychiatry

Volumn 12, Issue 1, 2013, Pages 4-15

  Keshavan, Matcheri S ^a   Kaneko, Yoshio ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

NMDA receptor encephalitis; Schizophrenia; Secondary psychoses; Temporal lobe epilepsy; Velocardiofacial syndrome

Indexed keywords

NEUROLEPTIC AGENT;

ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; DISEASE ASSOCIATION; HASHIMOTO DISEASE; HUMAN; HUNTINGTON CHOREA; IMMUNOSUPPRESSIVE TREATMENT; METABOLIC DISORDER; PRADER WILLI SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TEMPORAL LOBE EPILEPSY; TRAUMATIC BRAIN INJURY; VELOCARDIOFACIAL SYNDROME; WILSON DISEASE;

EID: 84877700699     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20001     Document Type: Article

References (163)

1. Mendel LB. The American Physiological Society. Science 1907; 26:765.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text revision. Washington: American Psychiatric Association, 2000.
3. Fujii D, Ahmed I. Characteristics of psychotic disorder due to traumatic brain injury: an analysis of case studies in the literature. J Neuropsychiatry Clin Neurosci 2002;14:130-40.
4. Achte KA, Hillbom E, Aalberg V. Psychoses following war brain injuries. Acta Psychiatr Scand 1969;45:1-18.
5. Silver JM, Kramer R, Greenwald S et al. The association between head injuries and psychiatric disorders: findings from the New Haven NIMH Epidemiologic Catchment Area Study. Brain Inj 2001;15:935-45.
6. Harrison G, Whitley E, Rasmussen F et al. Risk of schizophrenia and other non-affective psychosis among individuals exposed to head injury: case control study. Schizophr Res 2006;88:119-26.
7. David AS, Prince M. Psychosis following head injury: a critical review. J Neurol Neurosurg Psychiatry 2005;76 (Suppl. 1):i53-60.
8. Sachdev P, Smith JS, Cathcart S. Schizophrenia-like psychosis following traumatic brain injury: a chart-based descriptive and case-control study. Psychol Med 2001;31:231-9.
9. Cutting J. The phenomenology of acute organic psychosis. Comparison with acute schizophrenia. Br J Psychiatry 1987;151:324-32.
10. Miller BL, Benson DF, Cummings JL et al. Late-life paraphrenia: an organic delusional syndrome. J Clin Psychiatry 1986;47:204-7.
11. Sibley JT, Olszynski WP, Decoteau WE et al. The incidence and prognosis of central nervous system disease in systemic lupus ery-thematosus. J Rheumatol 1992;19:47-52.
12. Stojanovich L, Zandman-Goddard G, Pavlovich S et al. Psychiatric manifestations in systemic lupus erythematosus. Autoimmun Rev 2007;6:421-6.
13. Pego-Reigosa JM, Isenberg DA. Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease. Rheumatology 2008;47:1498-502.
14. Appenzeller S, Cendes F, Costallat LTL. Acute psychosis in systemic lupus erythematosus. Rheumatol Int 2008;28:237-43.
15. Ward MM, Studenski S. The time course of acute psychiatric episodes in systemic lupus erythematosus. J Rheumatol 1991;18:535-9.
16. Carrieri PB, Montella S, Petracca M. Psychiatric onset of multiple sclerosis: description of two cases. J Neuropsychiatry Clin Neurosci 2011;23:E6.
17. Kosmidis MH, Giannakou M, Messinis L et al. Psychotic features associated with multiple sclerosis. Int Rev Psychiatry 2010;22: 55-66.
18. Lee M-J, Lee H-S, Hwang J-S et al. A case of Hashimoto's ence-phalopathy presenting with seizures and psychosis. Korean J Pediatr 2012;55:111-3.
19. de Holanda N, de Lima D. Hashimoto's encephalopathy: systematic review of the literature and an additional case. J Neuropsy-chiatry Clin Neurosci 2011;23:384-90.
20. Shprintzen RJ, Goldberg R, Golding-Kushner KJ et al. Late-onset psychosis in the velo-cardio-facial syndrome. Am J Med Genet 1992;42:141-2.
21. Pulver AE, Nestadt G, Goldberg R et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994;182:476-8.
22. Papolos DF, Faedda GL, Veit S et al. Bipolar spectrum disorders in patients diagnosed with velo-cardio-facial syndrome: does a hemizygous deletion of chromosome 22q11 result in bipolar affective disorder? Am J Psychiatry 1996;153:1541-7.
23. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999;56:940-5.
24. Chow EWC, Watson M, Young DA et al. Neurocognitive profile in 22q11 deletion syndrome and schizophrenia. Schizophr Res 2006;87:270-8.
25. Vogels A, Matthijs G, Legius E et al. Chromosome 15 maternal uniparental disomy and psychosis in Prader-Willi syndrome. J Med Genet 2003;40:72-3.
26. Vogels A, De Hert M, Descheemaeker MJ et al. Psychotic disorders in Prader-Willi syndrome. Am J Med Genet A 2004;15; 127A:238-43.
27. Folstein SE, Chase GA, Wahl WE et al. Huntington disease in Maryland: clinical aspects of racial variation. Am J Hum Genet 1987;41:168-79.
28. Shiwach R. Psychopathology in Huntington's disease patients. Acta Psychiatr Scand 1994;90:241-6.
29. Bourgeois JA. Fahr's disease-a model of neuropsychiatric illness with cognitive and psychotic symptoms. Acta Psychiatr Scand 2010;121:78.
30. Shakibai SV, Johnson JP, Bourgeois JA. Paranoid delusions and cognitive impairment suggesting Fahr's disease. Psychosomatics 2005;46:569-72.
31. Curran C, Byrappa N, McBride A. Stimulant psychosis: systematic review. Br J Psychiatry 2004;185:196-204.
32. Post RM. Cocaine psychoses: a continuum model. Am J Psychiatry 1975;132:225-31.
33. Thirthalli J, Benegal V. Psychosis among substance users. Curr Opin Psychiatry 2006;19:239-45.
34. Fergusson DM, Horwood LJ, Swain-Campbell NR. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003;33:15-21.
35. Fergusson DM, Horwood LJ, Ridder EM. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005; 100:354-66.
36. Erard R, Luisada PV, Peele R The PCP psychosis: prolonged intoxication or drug-precipitated functional illness? J Psychedelic Drugs 1980;12:235-51.
37. Jansen KL. A review of the nonmedical use of ketamine: use, users and consequences. J Psychoactive Drugs 2000;32:419-33.
38. Hambrecht M, Hafner H. Do alcohol or drug abuse induce schizophrenia? Nervenarzt 1996;67:36-45.
39. Dalmau A, Bergman B, Brismar B. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness? Eur Psychiatry 1999;14:366-71.
40. Cami J, Farre M, Mas M et al. Human pharmacology of 3, 4-meth-ylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effects. J Clin Psychopharmacol 2000;20:455-66.
41. Cole JC, Sumnall HR. Altered states: the clinical effects of Ecstasy. Pharmacol Ther 2003;98:35-58.
42. Kahan VL. Paranoid states occurring in leaded-petrol handlers. J Ment Sci 1950;96:1043-7.
43. Schenk VW, Stolk PJ. Psychosis following arsenic (possibly thallium) poisoning. A clinical-neuropathological report. Psychiatr Neurol Neurochir 1967;70:31-7.
44. Dubovsky AN, Arvikar S, Stern TA et al. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited. Psychosomatics 2012;53:103-15.
45. Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs Aging 1993;3:335-48.
46. Peters NL. Snipping the thread of life. Antimuscarinic side effects of medications in the elderly. Arch Intern Med 1989;149:2414-20.
47. Schor JD, Levkoff SE, Lipsitz LA et al. Risk factors for delirium in hospitalized elderly. JAMA 1992;267:827-31.
48. Marcantonio ER, Juarez G, Goldman L et al. The relationship of postoperative delirium with psychoactive medications. JAMA 1994;272:1518-22.
49. Schrestha S, Alao A. Isoniazid-induced psychosis. Psychosomatics 2009;50:640-1.
50. Tran TM, Browning J, Dell ML. Psychosis with paranoid delusions after a therapeutic dose of mefloquine: a case report. Malar J2006;5:74.
51. Alisky JM, Chertkova EL, Iczkowski KA. Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis. Med Hypotheses 2006;67:1090-4.
52. Gustafson Y, Berggren D, Brannstrom B et al. Acute confusional states in elderly patients treated for femoral neck fracture. J Am Geriatr Soc 1988;36:525-30.
53. Meador KJ. Cognitive side effects of antiepileptic drugs. Can J Neurol Sci 1994;21:S12-6.
54. Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996;275:852-7.
55. Bowen JD, Larson EB. Drug-induced cognitive impairment. Defining the problem and finding solutions. Drugs Aging 1993; 3:349-57.
56. Martin NJ, Stones MJ, Young JE et al. Development of delirium: a prospective cohort study in a community hospital. Int Psychoger-iatr 2000;12:117-27.
57. Snavely S. The neurotoxicity of antibacterial agents. Ann Intern Med 1984;101:92-104.
58. Almeida OP, Xiao J. Mortality associated with incident mental health disorders after stroke. Aust N Z J Psychiatry 2007;41:274-81.
59. Kumral E, Ozturk O. Delusional state following acute stroke. Neurology 2004;62:110-3.
60. Nagaratnam N, O'Neile L. Delusional parasitosis following occi-pito-temporal cerebral infarction. Gen Hosp Psychiatry 2000; 22:129-32.
61. Beniczky S, Keri S, Voros E et al. Complex hallucinations following occipital lobe damage. Eur J Neurol 2002;9:175-6.
62. Nye E, Arendts G Intracerebral haemorrhage presenting as olfactory hallucinations. Emerg Med 2002;14:447-9.
63. Starkstein S, Robinson R. Post-stroke hallucinatory delusional syndromes. Neuropsychiatry Neuropsychol Behav Neurol 1992; 5:114-8.
64. Lyketsos CG, Steinberg M, Tschanz JT et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry 2000;157:708-14.
65. Sachdev PS, Keshavan MS. Secondary schizophrenia. Cambridge: Cambridge University Press, 2010.
66. Waggoner RW, Bagchi BK. Initial masking of organic brain changes by psychic symptoms: clinical and electroencephalo-graphic studies. Am J Psychiatry 1954;110:904-10.
67. Klotz M. Incidence of brain tumors in patients hospitalized for chronic mental disorders. Psychiatr Q 1957;31:669-80.
68. Larson C. Intracranial tumors in mental hospital patients a statistical study. Am J Psychiatry 1940;97:49-58.
69. Mulder DW, Daly D. Psychiatric symptoms associated with lesions of temporal lobe. JAMA 1952;150:173-6.
70. Selecki BR. Intracranial space-occupying lesions among patients admitted to mental hospitals. Med J Aust 1965;1:383-90.
71. Malamud N. Psychiatric disorder with intracranial tumors of limbic system. Arch Neurol 1967;17:113-23.
72. Galasko D, Kwo-On-Yuen PF, Thal L. Intracranial mass lesions associated with late-onset psychosis and depression. Psychiatr Clin North Am 1988;11:151-66.
73. Edwards-Lee T. Focal lesions and psychosis. In: Bogousslavsky J, Cummings JL (eds). Behavior and mood disorders. Cambridge: Cambridge University Press, 2000:419-36.
74. Davison K, Bagley CR. Schizophrenia-like psychoses associated with organic disorder of the central nervous system: a review of the literature. In: Herrington RN (ed). Current problems in neuropsychiatry. Ashford: Headley Brothers, 1969:1-45.
75. Hollister LE, Boutros N. Clinical use of CT and MR scans in psychiatric patients. J Psychiatry Neurosci 1991;16:194-8.
76. Benes F. Why does psychosis develop during adolescence and early adulthood? Curr Opin Psychiatry 2003;16:317-9.
77. Feinberg I. Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982; 17:319-34.
78. Benes FM. Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull 1989;15:585-93.
79. Weinberger DR, Lipska BK. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 1995;16:87-110.
80. Mizukami K, Sasaki M, Suzuki T et al. Central nervous system changes in mitochondrial encephalomyopathy: light and electron microscopic study. Acta Neuropathol 1992;83:449-52.
81. Suzuki T, Koizumi J, Shiraishi H et al. Psychiatric disturbance in mitochondrial encephalomyopathy. J Neurol Neurosurg Psychiatry 1989;52:920-2.
82. Amemiya S, Hamamoto M, Goto Y et al. Psychosis and progressing dementia: presenting features of a mitochondriopathy. Neurology 2000;55:600-1.
83. Huang CC, Chu NS. Wilson's disease: clinical analysis of 71 cases and comparison with previous Chinese series. J Formos Med Assoc 1992;91:502-7.
84. Rathbun J. Neuropsychological aspects of Wilson's disease. Int J Neurosci 1996;85:221-9.
85. Wilson S. Progressive lenticular degeneration. BMJ 1912; 2:1645.4.
86. Lindenbaum J, Healton EB, Savage DG et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720-8.
87. Hutto BR. Folate and cobalamin in psychiatric illness. Compr Psychiatry 1997;38:305-14.
88. Evans DL, Edelsohn GA, Golden RN. Organic psychosis without anemia or spinal cord symptoms in patients with vitamin B12 deficiency. Am J Psychiatry 1983;140:218-21.
89. Masalha R Chudakov B, Muhamad M et al. Cobalamin-respon-sive psychosis as the sole manifestation of vitamin B12 deficiency. Isr Med Assoc J 2001;3:701-3.
90. Payinda G, Hansen T. Vitamin B(12) deficiency manifested as psychosis without anemia. Am J Psychiatry 2000;157:660-1.
91. Levitt AJ, Joffe RT. Vitamin B12 in psychotic depression. Br J Psychiatry 1988;153:266-7.
92. Godfrey PS, Toone BK, Carney MW et al. Enhancement of recovery from psychiatric illness by methylfolate. Lancet 1990; 336:392-5.
93. Prakash R, Gandotra S, Singh LK et al. Rapid resolution of delusional parasitosis in pellagra with niacin augmentation therapy. Gen Hosp Psychiatry 2008;30:581-4.
94. Rudin DO. The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra. Biol Psychiatry 1981;16:837-50.
95. Hare EH. The origin and spread of dementia paralytica. J Ment Sci 1959;105:594-626.
96. Sobhan T, Rowe HM, Ryan WG et al. Unusual case report: three cases of psychiatric manifestations of neurosyphilis. Psychiatr Serv 2004;55:830-2.
97. Klaus MV, Amarante L, Beam TR Routine screening for syphilis is justified in patients admitted to psychiatric, alcohol, and drug rehabilitation wards of the Veterans Administration Medical Center. Arch Dermatol 1989;125:1644-6.
98. Hutto B. Syphilis in clinical psychiatry: a review. Psychosomatics 2001;42:453-60.
99. Taycan O, Ugur M, Ozmen M. Quetiapine vs. risperidone in treating psychosis in neurosyphilis: a case report. Gen Hosp Psychiatry 2006;28:359-61.
100. Guler E, Leyhe T. A late form of neurosyphilis manifesting with psychotic symptoms in old age and good response to ceftriaxone therapy. Int Psychogeriatr 2011;23:666-9.
101. Sewell DD. Schizophrenia and HIV. Schizophr Bull 1996; 22:465-73.
102. Dolder CR Patterson TL, Jeste DV. HIV, psychosis and aging: past, present and future. AIDS 2004;18 (Suppl. 1):S35-42.
103. Harris MJ, Jeste DV, Gleghorn A et al. New-onset psychosis in HIV-infected patients. J Clin Psychiatry 1991;52:369-76.
104. Shedlack KJ, Soldato-Couture C, Swanson CL. Rapidly progressive tardive dyskinesia in AIDS. Biol Psychiatry 1994;35:147-8.
105. Yolken RH, Dickerson FB, Fuller Torrey E. Toxoplasma and schizophrenia. Parasite Immunol 2009;31:706-15.
106. Torrey EF, Yolken RH. Schizophrenia and toxoplasmosis. Schizophr Bull 2007;33:727-8.
107. Kramer W. Frontiers of neurological diagnosis in acquired toxoplasmosis. Psychiatr Neurol Neurochir 1966;69:43-64.
108. Freytag HW, Haas H. Psychiatric aspects of acquired toxoplasmosis. A case report. Nervenarzt 1979;50:128-31.
109. Brown AS. Epidemiologic studies of exposure to prenatal infection and risk of schizophrenia and autism. Dev Neurobiol (in press).
110. Brown AS, Begg MD, Gravenstein S et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004;61:774-80.
111. Mortensen PB, Nergaard-Pedersen B, Waltoft BL et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007;61:688-93.
112. Babulas V, Factor-Litvak P, Goetz R et al. Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry 2006;163:927-9.
113. Brown AS, Cohen P, Harkavy-Friedman J et al. Prenatal rubella, premorbid abnormalities, and adult schizophrenia. Biol Psychiatry 2001;49:473-86.
114. Patten SB, Svenson LW, Metz LM. Psychotic disorders in MS: population-based evidence of an association. Neurology 2005; 65:1123-5.
115. Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry 2004;49:157-63.
116. Feinstein A, Boulay du G, Ron MA. Psychotic illness in multiple sclerosis. A clinical and magnetic resonance imaging study. Br J Psychiatry 1992;161:680-5.
117. Ropacki SA, Jeste DV. Epidemiology of and risk factors for psychosis of Alzheimer's disease: a review of 55 studies published from 1990 to 2003. Am J Psychiatry 2005;162:2022-30.
118. Paulsen JS, Ready RE, Stout JC et al. Neurobehaviors and psychotic symptoms in Alzheimer's disease. J Int Neuropsychol Soc 2000;6:815-20.
119. Jeste DV, Finkel SI. Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome. Am J Geriatr Psychiatry 2000;8:29-34.
120. Rapoport MJ, van Reekum R, Freedman M et al. Relationship of psychosis to aggression, apathy and function in dementia. Int J Geriatr Psychiatry 2001;16:123-30.
121. Gustafson L, Brun A, Passant U. Frontal lobe degeneration of non-Alzheimer type. Baillieres Clin Neurol 1992;1:559-82.
122. Edwards-Lee T, Miller BL, Benson DF et al. The temporal variant of frontotemporal dementia. Brain 1997;120 (Pt 6):1027-40.
123. Logsdail SJ, Toone BK. Post-ictal psychoses. A clinical and phe-nomenological description. Br J Psychiatry 1988;152:246-52.
124. Kanner AM, Stagno S, Kotagal P et al. Postictal psychiatric events during prolonged video-electroencephalographic monitoring studies. Arch Neurol 1996;53:258-63.
125. Slater E, Beard AW, Glithero E. The schizophrenia-like psychoses of epilepsy. Br J Psychiatry 1963;109:95-150.
126. Qin P, Xu H, Laursen TM et al. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy: population based cohort study. BMJ 2005;331:23.
127. Standage KF, Fenton GW. Psychiatric symptom profiles of patients with epilepsy: a controlled investigation. Psychol Med 1975;5:152-60.
128. Katsigiannopoulos K, Georgiadou E, Pazarlis P et al. Psychotic disorder as a manifestation of Graves' disease. Psychosomatics 2010;51:449-50.
129. Chen T-S, Wen M-J, Hung Y-J et al. A rare storm in a psychiatric ward: thyroid storm. Gen Hosp Psychiatry 2012;34:210.e1-4.
130. Brownlie BE, Rae AM, Walshe JW et al. Psychoses associated with thyrotoxicosis-"thyrotoxic psychosis". A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol 2000;142:438-44.
131. Rizvi AA. "Thyrotoxic psychosis" associated with subacute thy-roiditis. South Med J 2007;100:837-40.
132. Kobayashi N, Tajiri J, Takano M. Transient psychosis due to painless thyroiditis in a patient with anxiety disorder: a case report. J Med Case Reports 2011;5:534.
133. Sathya A, Radhika R, Mahadevan S et al. Mania as a presentation of primary hypothyroidism. Singapore Med J 2009;50:e65-7.
134. Tor PC, Lee HY, Fones CSL. Late-onset mania with psychosis associated with hypothyroidism in an elderly Chinese lady. Singapore Med J 2007;48:354-7.
135. Hall R. Psychiatric effects of thyroid hormone disturbance. Psy-chosomatics 1983;24:7-11.
136. Heinrich TW, Grahm G. Hypothyroidism presenting as psychosis: myxedema madness revisited. Prim Care Companion J Clin Psychiatry 2003;5:260-6.
137. Irwin R, Ellis PM, Delahunt J. Psychosis following acute alteration of thyroid status. Aust N Z J Psychiatry 1997;31:762-4.
138. Schofield A, Bracken P. Thyroid-induced psychosis in myxoe-dema. Ir Med J 1983;76:495-6.
139. Papa A, Bononi F, Sciubba S et al. Primary hyperparathyroid-ism: acute paranoid psychosis. Am J Emerg Med 2003;21:250-1.
140. Watson LC, Marx CE. New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism. Psychoso-matics 2002;43:413-7.
141. Velasco PJ, Manshadi M, Breen K et al. Psychiatric aspects of parathyroid disease. Psychosomatics 1999;40:486-90.
142. Denko JD, Kaelbling R. The psychiatric aspects of hypoparathyr-oidism. Acta Psychiatr Scand 1962;38 (Suppl. 164):1-70.
143. Ang AW, Ko SM, Tan CH. Calcium, magnesium, and psychotic symptoms in a girl with idiopathic hypoparathyroidism. Psycho-som Med 1995;57:299-302.
144. Lisanby S, Kohler C, Swanson C. Psychosis secondary to brain tumor. Semin Clin Neuropsychiatry 1998;3:12-22.
145. Illes J, Kirschen M, Edwards E et al. Incidental findings in brain imaging research: what should happen when a researcher sees a potential health problem in a brain scan from a research subject? Science 2006;311:783-84.
146. Lawrie SM, Abukmeil SS, Chiswick A et al. Qualitative cerebral morphology in schizophrenia: a magnetic resonance imaging study and systematic literature review. Schizophr Res 1997; 24;25:155-66.
147. Keshavan MS, DeLisi LE, Seidman LJ. Early and broadly defined psychosis risk mental states. Schizophr Res 2011;126:1-10.
148. Shenton ME, Whitford TJ, Kubicki M. Structural neuroimaging in schizophrenia: from methods to insights to treatments. Dialogues Clin Neurosci 2010;12:317-32.
149. Keshavan MS, Tandon R, Boutros NN et al. Schizophrenia, "just the facts": what we know in 2008. Part 3: Neurobiology. Schiz-ophr Res 2008;106:89-107.
150. Tandon R, Keshavan MS, Nasrallah HA. Schizophrenia, "just the facts": what we know in 2008. 2. Epidemiology and etiology. Schizophr Res 2008;102:1-18.
151. Trimble M. The psychoses of epilepsy. New York: Raven, 1991.
152. Torta R, Keller R. Behavioral, psychotic, and anxiety disorders in epilepsy: etiology, clinical features, and therapeutic implications. Epilepsia 1999;40 (Suppl. 10):S2-20.
153. Ando N, Morimoto K, Watanabe T et al. Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis. Neuropsychopharmacology 2004;29:1251-8.
154. Shashi V, Keshavan MS, Howard TD et al. Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome. Clin Genet 2006;69:234-8.
155. Shashi V, Kwapil TR, Kaczorowski J et al. Evidence of gray matter reduction and dysfunction in chromosome 22q11.2 deletion syndrome. Psychiatry Res 2010;181:1-8.
156. Kates WR, Antshel KM, Faraone SV et al. Neuroanatomic predictors to prodromal psychosis in velocardiofacial syndrome (22q11.2 deletion syndrome): a longitudinal study. Biol Psychiatry 2011;69:945-52.
157. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 1995;52:998-1007.
158. Moghaddam B. Bringing order to the glutamate chaos in schizophrenia. Neuron 2003;40:881-4.
159. Harrison PJ, Law AJ, Eastwood SL. Glutamate receptors and transporters in the hippocampus in schizophrenia. Ann N Y Acad Sci 2003;1003:94-101.
160. Gonzalez-Burgos G, Hashimoto T, Lewis DA. Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep 2010;12:335-44.
161. Potvin S, Stip E, Sepehry AA et al. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008;63:801-8.
162. Dalmau J, Tuzun E, Wu H-Y et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36.
163. Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol 2008;7:327-40.